The pros and cons of lamivudine vs. entecavir in decompensated or severe acute exacerbation of chronic hepatitis B

Journal of Hepatology

Volumn 60, Issue 6, 2014, Pages 1108-1109

  Shouval, Daniel ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ENTECAVIR; LAMIVUDINE; TELBIVUDINE; TENOFOVIR; GUANINE;

ACUTE DISEASE; ANTIVIRAL THERAPY; CHRONIC HEPATITIS; DECOMPENSATED LIVER CIRRHOSIS; DISEASE EXACERBATION; DRUG COST; DRUG EFFICACY; DRUG SAFETY; DRUG TREATMENT FAILURE; HEPATIC ENCEPHALOPATHY; HEPATITIS B; HUMAN; LACTIC ACIDOSIS; LIVER TRANSPLANTATION; META ANALYSIS (TOPIC); MITOCHONDRIAL TOXICITY; NOTE; PATIENT REFERRAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEPTICEMIA; VIRUS LOAD; COMPARATIVE STUDY; DISEASE SEVERITY; SHORT SURVEY; ACUTE-ON-CHRONIC LIVER FAILURE; ANALOGS AND DERIVATIVES; END STAGE LIVER DISEASE; FEMALE; GENETICS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; MALE;

ACUTE-ON-CHRONIC LIVER FAILURE; END STAGE LIVER DISEASE; FEMALE; GUANINE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LAMIVUDINE; MALE;

EID: 84901234063     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.03.004     Document Type: Note

References (12)

1. Y.F. Liaw, and C.M. Chu Hepatitis B virus infection Lancet 373 2009 582 592
2. R.N. Chien, C.H. Lin, and Y.F. Liaw The effect of lamivudine therapy in hepatic decompensation during acute exacerbation of chronic hepatitis B J Hepatol 38 2003 322 327
3. Y.F. Liaw, I.S. Sheen, C.M. Lee, U.S. Akarca, G.V. Papatheodoridis, and F. Suet-Hing Wong et al. Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease Hepatology 53 2011 62 72
4. B. Roche, and D. Samuel Treatment of patients with HBV-related decompensated cirrhosis and liver transplanted patients Clin Liver Dis 17 2013 451 473
5. J. Fung, W.K. Seto, C.L. Lai, and M.F. Yuen Extrahepatic effects of nucleoside and nucleotide analogues in chronic hepatitis B treatment J Gastroenterol Hepatol 29 2014 428 434
6. C.M. Lange, J. Bojunga, W.P. Hofmann, K. Wunder, U. Mihm, and S. Zeuzem et al. Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function Hepatology 50 2009 2001 2006
7. V.W. Wong, G.L. Wong, K.K. Yiu, A.M. Chim, S.H. Chu, and H.Y. Chan et al. Entecavir treatment in patients with severe acute exacerbation of chronic hepatitis B J Hepatol 54 2011 236 242
8. A. Marzano, A. Marengo, M. Marietti, and M. Rizzetto Lactic acidosis during Entecavir treatment in decompensated hepatitis B virus-related cirrhosis Dig Liver Dis 43 2011 1027 1028
9. T. Chen, Y. He, X. Liu, Z. Yan, K. Wang, and H. Liu et al. Nucleoside analogues improve the short-term and long-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure Clin Exp Med 12 2012 159 164
10. Y.L. Cui, F. Yan, Y.B. Wang, X.Q. Song, L. Liu, and X.Z. Lei et al. Nucleoside analogue can improve the long-term prognosis of patients with hepatitis B virus infection-associated acute on chronic liver failure Dig Dis Sci 55 2010 2373 2380
11. X.G. Ye, and Q.M. Su Effects of entecavir and lamivudine for hepatitis B decompensated cirrhosis: meta-analysis World J Gastroenterol 19 2013 6665 6678
12. C.H. Chen, C.L. Lin, T.H. Hu, C.H. Hung, P.L. Tseng, and J.H. Wang et al. Entecavir vs. lamivudine in chronic hepatitis B patients with severe acute exacerbation and hepatic decompensation J Hepatol 60 2014 1127 1134.